Corrigendum to ‘Should treatment of low-level rifampicin mono-resistant tuberculosis be different?’ [JCTUBE 23 (2021) 100241]

by F.A. Gopie, E. Commiesie, W.C.M. de Lange, D. van Soolingen, S.G.S. Vreden, G. de Vries
Published 2021-08-01

Should treatment of low-level mono-resistant tuberculosis be different?

by F.A. Gopie, E. Commiesie, W.C.M. de Lange, D. van Soolingen, S.G.S. Vreden, G. de Vries
Published 2021-05-01

Should treatment of low-level rifampicin mono-resistant tuberculosis be different?

by F.A. Gopie, E. Commiesie, S. Baldi, M. Kamst, D. Kaur, W.C.M. de Lange, P.S. Pinas, D. Stijnberg, M. Wongsokarijo, C.W.R. Zijlmans, R. de Zwaan, D. van Soolingen, S.G.S. Vreden, G. de Vries
Published 2021-05-01